Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Br J Med Med Res ; 2016; 15(2): 1-12
Article in English | IMSEAR | ID: sea-182976

ABSTRACT

Aims: The aim of this exploratory study was to clarify the differences between the prostatic levels of trace elements in patients with benign prostatic hyperplasia (BPH) and healthy male inhabitants. Methodology: We prospectively evaluated the prostatic levels of 43 trace elements in 32 patients with BPH and 32 healthy males. Measurements were performed using instrumental neutron activation analysis with high resolution spectrometry of long-lived radionuclides combined with inductively coupled plasma mass spectrometry. Results: In the hyperplastic prostates a significant increase in the mean level of Bi, Cr, Hg, Sb, and Se and a significant decrease in the mean level of Ce, Cs, Dy, Er, Gd, Ho, La, Mo, Nd, Pb, Pr, Sm, Sn, Tb, Tm, U, and Y was observed. It was not found any differences in the mean prostatic level of Ag, Al, Au, B, Be, Br, Cd, Co, Fe, Li, Mn, Nb, Ni, Rb, Sc, Th, Ti, Tl, Yb, Zn, and Zr between BPH-patients and healthy males. Conclusion: Present study finding of trace element contents and correlation between pairs of trace element mass fractions indicates that there is a great disturbance of prostatic trace element metabolism in BPH gland. Obtained data did not confirm a critical role of Cd and Pb accumulation in the pathogenesis of BPH. A potential age-related Zn, Fe, and Se deficiency in the prostate has not been found as being involved in the etiology of BPH. This work data cast doubts on a beneficial effect of the Zn, Fe, and Se supplementations on BPH prevention and treatment. Additional studies of other chemical elements in BPH are planned.

2.
Br J Med Med Res ; 2015; 8(8): 692-706
Article in English | IMSEAR | ID: sea-180713

ABSTRACT

Aims: To clarify the changes in morphometric parameters and contents of zinc (Zn) and in the relationship between these characteristics in normal and hyperplastic human prostates, a quantitative morphometry and energy-dispersive X-ray fluorescence analysis was performed. Methodology: Samples of the human prostate of mass under 30 g were obtained from randomly selected autopsy specimens of 35 men (European-Caucasian aged 40-87 years) who died mainly from trauma. All prostate glands were divided into two portions, each with an anterior-posterior cross-section: one tissue portion was reviewed by an anatomical pathologist while the other was used for the Zn mass fraction measurement. After preliminary histological investigation the subjects were divided into a control group (n=24) and a benign prostatic hyperplasia (BPH) group (n=11). The mean percent volume of the stroma (S), glandular epithelium (E), glandular lumen (L) and glandular component (GC=E+L) were determined, and the mean ratios of percent volumes (S/E, S/GC, and E/L) were calculated for each prostate specimen. Results: Increases in E (33.6% vs 26.7%) and GC (52.3% vs 44.4%) and also a decrease in S (47.7% vs 55.6%), S/E ratio (1.53 vs 2.31) and S/GC ratio (0.97 vs 1.40) were observed, when values for Zn mass fraction in the earliest stage of BPH were compared with normality. A significant positive correlation between Zn and L (r = 0.65, P0.001) and between Zn and GC (r = 0.45, P0.05) and also a negative correlation between Zn and S (r = - 0.45, P0.05), between Zn and E/L ratio (r = - 0.63, P0.001), and between Zn and S/GC ratio (r = - 0.42, P0.05) was seen in histologically normal prostate tissue. A negative correlation between Zn and S and a positive correlation between Zn and L disappeared in the earliest stage of hyperplastic change. It means that a homeostatic control of Zn level in the histological structures of prostate tissue was partially destroyed. Conclusion: For the first time it was quantitatively shown that BPH begins from the excessive proliferation of the glandular epithelium and that the Zn redistribution in the histological structures of prostate tissue is a pathogenetic factor of the disease.

SELECTION OF CITATIONS
SEARCH DETAIL